Riskpilot← Back to searchSign inGet full accessNG Medical AB
ABActiveOrg 5591872899StockholmEconomic activity was not specified by tax authority · NACE 0000Est. 20180 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 15K
+119% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK 15K | +119% |
| Total assets | SEK 254K | -3% |
| Equity | SEK 254K | +6% |
| Employees | 0 | — |
Legal name
NG Medical AB
Org number
5591872899
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
19 december 2018
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, bedriva verksamhet inom utveckling och försäljning av medicinska produkter (och liknande rekreationsprodukter), förvalta lös och fast egendom och därmed förenlig verksamhet.
Address
Stockholm
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −109 | −6 | 42 | −65 | — |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −109 | −6 | 42 | −65 | 0 |
| Net financials | 46 | — | −9 352 | −13 | 16 |
| Profit before tax | −155 | −6 | −4 635 | −78 | 15 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −155 | −6 | −4 635 | −78 | 15 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 090 | 5 030 | 349 | 261 | 254 |
| Equity | 4 958 | 4 951 | 317 | 239 | 254 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 133 | 79 | 32 | 22 | 0 |
| Total debt | 133 | 79 | 32 | 22 | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
5.9%
This company
18.4%
Market median
-68% vs market
20202024
Net profit margin
1500000.0%
This company
8.1%
Market median
+18518419% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RE Authorized Recipient of Service | Authorized Recipient of Service | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NG Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Robin Eli Dangoor | Authorized Recipient of Service | 0 companies |
| Anthony Michael Romano | Chairman | 0 companies |
| Alejandro Romero | Board of Directors | 0 companies |
| Warren Paine Baker III | Board of Directors | 0 companies |
| Jonkheer Alexis Leopold Den Beer Poortugael | Board of Directors | 0 companies |